Bacteriophage-mediated immunisation
    2.
    发明授权
    Bacteriophage-mediated immunisation 有权
    噬菌体介导的免疫

    公开(公告)号:US07128916B2

    公开(公告)日:2006-10-31

    申请号:US10473664

    申请日:2002-03-25

    摘要: The present invention relates to vaccines comprising a bacteriophage which has been engineered to express an immunogenic protein/peptide and wherein the surface of the bacteriophage has not been modified to contain proteins/peptides designed to target the phage to receptors on the surface of specific cell types.

    摘要翻译: 本发明涉及包含已经被工程化以表达免疫原性蛋白质/肽的噬菌体的疫苗,并且其中噬菌体的表面未被修饰以包含被设计为将噬菌体靶向特定细胞类型的表面上的受体的蛋白质/肽 。

    Equine parasite detection
    4.
    发明授权
    Equine parasite detection 有权
    马寄生虫检测

    公开(公告)号:US09239330B2

    公开(公告)日:2016-01-19

    申请号:US14193380

    申请日:2014-02-28

    IPC分类号: G01N33/569 G01N33/53

    摘要: The present invention provides a method of diagnosing a cyathostomin infection, said method comprising the step of identifying a level of anti-cyathostomin larval antigen antibodies in a sample, wherein a level of anti-cyathostomin larval antigen antibodies is indicative of a cyathostomin infection.

    摘要翻译: 本发明提供了一种诊断细胞宿主感染的方法,所述方法包括鉴定样品中抗细胞死亡宿主抗原抗体水平的步骤,其中抗细胞死亡宿主抗原抗体水平表示细胞宿主病毒感染。

    EQUINE PARASITE DETECTION
    7.
    发明申请
    EQUINE PARASITE DETECTION 审中-公开
    EQUINE PARASITE检测

    公开(公告)号:US20140242619A1

    公开(公告)日:2014-08-28

    申请号:US14193380

    申请日:2014-02-28

    IPC分类号: G01N33/569

    摘要: The present invention provides a method of diagnosing a cyathostomin infection, said method comprising the step of identifying a level of anti-cyathostomin larval antigen antibodies in a sample, wherein a level of anti-cyathostomin larval antigen antibodies is indicative of a cyathostomin infection.

    摘要翻译: 本发明提供了一种诊断细胞宿主感染的方法,所述方法包括鉴定样品中抗细胞死亡宿主抗原抗体水平的步骤,其中抗细胞死亡宿主抗原抗体水平表示细胞宿主病毒感染。

    SMALL RUMINANT LENTIVIRUS VECTOR
    10.
    发明申请

    公开(公告)号:US20220228169A1

    公开(公告)日:2022-07-21

    申请号:US17608031

    申请日:2020-05-01

    IPC分类号: C12N15/86 A61K39/21

    摘要: The disclosure provides a plasmid and a lentiviral vector system which may be used to generate lentiviral vector particles for use in transduction. The disclosed vector system and/or plasmid improves the transduction efficiency of the generated lentiviral vector particles and may be exploited to provide compositions for raising immune responses in animals and as vaccines.